Tadalafil VersaFilmTM

Tadalafil VersaFilmTM
Product Description

Tadalafil film is a new product opportunity formulated using VersaFilm™, IntelGenx’s proprietary thin film technology. 

 Key Licensing Highlights

  • The first oral thin film using IntelGenx proprietary drug delivery technology, VersaFilm™, for erectile dysfunction
  • Containing tadalafil (Cialis® - Eli Lilly), a major molecule in the erectile dysfunction market
  • Demonstrated bioequivalence to Cialis®
  • Orally disintegrating films without need for water provide unprecedented patient convenience and a discrete dosing alternative
  • Exclusive rights from Eli Lilly to commercialize the film in the U.S. translates to opportunity to secure patients ahead of the expected generic tadalafil tablet forms
  • IntelGenx offers strong expertise in formulation and process development as well as manufacturing capability
  • Strong management team with a proven track record of success in working with commercialization partners

IntelGenx is currently looking for a partnership or alliance opportunity to commercialize tadalafil VersaFilm™.

Read more Show less

IntelGenx

  • CA
  • 2015
    On CPHI since
  • 25 - 49
    Employees
Company types
CMO/CDMO
View company profile
Categories
more categories Show less
Sales Markets
Show more Show less

IntelGenx

  • CA
  • 2015
    On CPHI since
  • 25 - 49
    Employees
Company types
CMO/CDMO
View company profile

More Products from IntelGenx (6)

  • VersaFilmTM - Oral Film Technology

    Product VersaFilmTM - Oral Film Technology

    VersaFilm™ is our proprietary delivery technology platform that enables the development of pharmaceutical films with potential to improve product performance: • Rapid disintegration without the need for water • Quicker buccal or sublingual absorption • Potential for faster onset of action and incr...
  • VetaFilmTM - Veterinary Oral Film Technology

    Product VetaFilmTM - Veterinary Oral Film Technology

    VetaFilm™ is our proprietary veterinary oral film technology that provides significant market opportunities to improve drug delivery for companion animals. VetaFilm™ research and development services and veterinary oral films provide: • Dose placed directly on oral mucosa or on their f...
  • Development & Manufacturing by Contract

    Product Development & Manufacturing by Contract

    IntelGenx offers full service to foster the growth of its partners. Our State-of-the-art facilities are equipped with the most modem equipment to deliver high-quality, cost-effective film products, while accommodating client requirements at each stage of product development. Int...
  • Rizaport® - Rizatriptan VersaFilmTM

    Product Rizaport® - Rizatriptan VersaFilmTM

    Rizaport®  is a novel, competitive and differentiated oral thin film formulation of rizatriptan for the acute treatment of migraine. 
     
    Key Licensing Highlights
    • Orally disintegrating film, without need for water, provides e...
  • Montelukast VersaFilmTM

    Product Montelukast VersaFilmTM

    Montelukast VersaFilm™ is an early stage pipeline opportunity that leverages the VersaFilm™ Technology for the treatment of degenerative diseases of the brain, such as mild cognitive impairment and Alzheimer's disease, the most prominent form of dementia.  IntelGenx is collabo...
  • Loxapine VersaFilmTM

    Product Loxapine VersaFilmTM

    Loxapine oral film utilizes IntelGenx' proprietary VersaFilm™ technology to allow for a fast and safe acting loxapine oral film dosage form, offering significant clinical benefits for patients with agitation associated with schizophrenia & bipolar 1 disorder.

    Key Licensing Highlights q...